Live Earnings Conference Call: Crescent Capital BDC will host a live Q1 2026 earnings call on May 14, 2026 at 12:00PM ET. Get details.

Crescent Capital BDC (CCAP) Competitors

$13.07 -0.15 (-1.13%)

Closing price 05/13/2026 04:00 PM Eastern

Extended Trading

$12.62 -0.45 (-3.40%)

As of 06:11 AM Eastern

Compare

CCAP vs. CGBD, MFIC, OCSL, SLRC, and BCSF

Should you buy Crescent Capital BDC stock or one of its competitors? MarketBeat compares Crescent Capital BDC with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Crescent Capital BDC include Carlyle Secured Lending (CGBD), MidCap Financial Investment (MFIC), Oaktree Specialty Lending (OCSL), SLR Investment (SLRC), and Bain Capital Specialty Finance (BCSF). These companies are all part of the "finance" sector.

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Crescent Capital BDC (NASDAQ:CCAP) and Carlyle Secured Lending (NASDAQ:CGBD) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability.

Carlyle Secured Lending has higher revenue and earnings than Crescent Capital BDC. Carlyle Secured Lending is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crescent Capital BDC	$167.29M	2.89	$34.51M	$0.94	13.90
Carlyle Secured Lending	$255.57M	3.02	$69.97M	$1.02	10.90

Crescent Capital BDC has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market. Comparatively, Carlyle Secured Lending has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market.

Crescent Capital BDC currently has a consensus target price of $15.50, indicating a potential upside of 18.59%. Carlyle Secured Lending has a consensus target price of $12.50, indicating a potential upside of 12.41%. Given Crescent Capital BDC's stronger consensus rating and higher probable upside, research analysts clearly believe Crescent Capital BDC is more favorable than Carlyle Secured Lending.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crescent Capital BDC	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71
Carlyle Secured Lending	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43

Crescent Capital BDC has a net margin of 20.64% compared to Carlyle Secured Lending's net margin of 19.52%. Crescent Capital BDC's return on equity of 9.32% beat Carlyle Secured Lending's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Crescent Capital BDC	20.64%	9.32%	4.07%
Carlyle Secured Lending	19.52%	8.99%	4.01%

In the previous week, Carlyle Secured Lending had 6 more articles in the media than Crescent Capital BDC. MarketBeat recorded 12 mentions for Carlyle Secured Lending and 6 mentions for Crescent Capital BDC. Carlyle Secured Lending's average media sentiment score of 1.30 beat Crescent Capital BDC's score of 0.84 indicating that Carlyle Secured Lending is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Crescent Capital BDC	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Carlyle Secured Lending	5 Very Positive mention(s)	4 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

49.5% of Crescent Capital BDC shares are held by institutional investors. Comparatively, 24.5% of Carlyle Secured Lending shares are held by institutional investors. 1.2% of Crescent Capital BDC shares are held by insiders. Comparatively, 0.6% of Carlyle Secured Lending shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 12.9%. Carlyle Secured Lending pays an annual dividend of $1.60 per share and has a dividend yield of 14.4%. Crescent Capital BDC pays out 178.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Carlyle Secured Lending pays out 156.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has raised its dividend for 1 consecutive years. Carlyle Secured Lending is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Carlyle Secured Lending beats Crescent Capital BDC on 10 of the 19 factors compared between the two stocks.

How does Crescent Capital BDC compare to MidCap Financial Investment?

Crescent Capital BDC (NASDAQ:CCAP) and MidCap Financial Investment (NASDAQ:MFIC) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, media sentiment, dividends, profitability, valuation and risk.

49.5% of Crescent Capital BDC shares are owned by institutional investors. Comparatively, 28.5% of MidCap Financial Investment shares are owned by institutional investors. 1.2% of Crescent Capital BDC shares are owned by company insiders. Comparatively, 0.8% of MidCap Financial Investment shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Crescent Capital BDC currently has a consensus target price of $15.50, indicating a potential upside of 18.59%. MidCap Financial Investment has a consensus target price of $11.54, indicating a potential upside of 4.77%. Given Crescent Capital BDC's stronger consensus rating and higher possible upside, equities analysts plainly believe Crescent Capital BDC is more favorable than MidCap Financial Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crescent Capital BDC	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71
MidCap Financial Investment	0 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.22

Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 12.9%. MidCap Financial Investment pays an annual dividend of $1.24 per share and has a dividend yield of 11.3%. Crescent Capital BDC pays out 178.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. MidCap Financial Investment pays out 3,100.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has raised its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Crescent Capital BDC has a net margin of 20.64% compared to MidCap Financial Investment's net margin of 1.90%. MidCap Financial Investment's return on equity of 10.86% beat Crescent Capital BDC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Crescent Capital BDC	20.64%	9.32%	4.07%
MidCap Financial Investment	1.90%	10.86%	4.31%

Crescent Capital BDC has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market. Comparatively, MidCap Financial Investment has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market.

In the previous week, MidCap Financial Investment had 6 more articles in the media than Crescent Capital BDC. MarketBeat recorded 12 mentions for MidCap Financial Investment and 6 mentions for Crescent Capital BDC. Crescent Capital BDC's average media sentiment score of 0.84 beat MidCap Financial Investment's score of 0.73 indicating that Crescent Capital BDC is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Crescent Capital BDC	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MidCap Financial Investment	3 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

MidCap Financial Investment has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than MidCap Financial Investment, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crescent Capital BDC	$167.29M	2.89	$34.51M	$0.94	13.90
MidCap Financial Investment	$320.88M	2.83	$63.17M	$0.04	275.25

Summary

Crescent Capital BDC beats MidCap Financial Investment on 13 of the 20 factors compared between the two stocks.

How does Crescent Capital BDC compare to Oaktree Specialty Lending?

Oaktree Specialty Lending (NASDAQ:OCSL) and Crescent Capital BDC (NASDAQ:CCAP) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends, risk and media sentiment.

Oaktree Specialty Lending pays an annual dividend of $1.60 per share and has a dividend yield of 13.3%. Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 12.9%. Oaktree Specialty Lending pays out 280.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out 178.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years.

Oaktree Specialty Lending has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market.

36.8% of Oaktree Specialty Lending shares are owned by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are owned by institutional investors. 0.3% of Oaktree Specialty Lending shares are owned by insiders. Comparatively, 1.2% of Crescent Capital BDC shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Crescent Capital BDC has a net margin of 20.64% compared to Oaktree Specialty Lending's net margin of 16.66%. Oaktree Specialty Lending's return on equity of 9.56% beat Crescent Capital BDC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oaktree Specialty Lending	16.66%	9.56%	4.60%
Crescent Capital BDC	20.64%	9.32%	4.07%

Oaktree Specialty Lending presently has a consensus price target of $11.83, suggesting a potential downside of 1.39%. Crescent Capital BDC has a consensus price target of $15.50, suggesting a potential upside of 18.59%. Given Crescent Capital BDC's stronger consensus rating and higher probable upside, analysts plainly believe Crescent Capital BDC is more favorable than Oaktree Specialty Lending.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oaktree Specialty Lending	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Crescent Capital BDC	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71

In the previous week, Oaktree Specialty Lending had 1 more articles in the media than Crescent Capital BDC. MarketBeat recorded 7 mentions for Oaktree Specialty Lending and 6 mentions for Crescent Capital BDC. Oaktree Specialty Lending's average media sentiment score of 0.88 beat Crescent Capital BDC's score of 0.84 indicating that Oaktree Specialty Lending is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oaktree Specialty Lending	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Crescent Capital BDC	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Crescent Capital BDC has lower revenue, but higher earnings than Oaktree Specialty Lending. Crescent Capital BDC is trading at a lower price-to-earnings ratio than Oaktree Specialty Lending, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oaktree Specialty Lending	$316.80M	3.34	$33.92M	$0.57	21.05
Crescent Capital BDC	$167.29M	2.89	$34.51M	$0.94	13.90

Summary

Crescent Capital BDC beats Oaktree Specialty Lending on 12 of the 20 factors compared between the two stocks.

How does Crescent Capital BDC compare to SLR Investment?

SLR Investment (NASDAQ:SLRC) and Crescent Capital BDC (NASDAQ:CCAP) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends, risk and media sentiment.

SLR Investment pays an annual dividend of $1.64 per share and has a dividend yield of 12.6%. Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 12.9%. SLR Investment pays out 100.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out 178.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

SLR Investment has a beta of 0.71, suggesting that its share price is 29% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market.

35.3% of SLR Investment shares are owned by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are owned by institutional investors. 8.8% of SLR Investment shares are owned by insiders. Comparatively, 1.2% of Crescent Capital BDC shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

SLR Investment has a net margin of 41.81% compared to Crescent Capital BDC's net margin of 20.64%. Crescent Capital BDC's return on equity of 9.32% beat SLR Investment's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SLR Investment	41.81%	8.33%	3.25%
Crescent Capital BDC	20.64%	9.32%	4.07%

SLR Investment presently has a consensus price target of $14.40, suggesting a potential upside of 10.77%. Crescent Capital BDC has a consensus price target of $15.50, suggesting a potential upside of 18.59%. Given Crescent Capital BDC's stronger consensus rating and higher probable upside, analysts plainly believe Crescent Capital BDC is more favorable than SLR Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SLR Investment	3 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.86
Crescent Capital BDC	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71

In the previous week, SLR Investment had 6 more articles in the media than Crescent Capital BDC. MarketBeat recorded 12 mentions for SLR Investment and 6 mentions for Crescent Capital BDC. Crescent Capital BDC's average media sentiment score of 0.84 beat SLR Investment's score of 0.09 indicating that Crescent Capital BDC is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SLR Investment	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Neutral
Crescent Capital BDC	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SLR Investment has higher revenue and earnings than Crescent Capital BDC. SLR Investment is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SLR Investment	$218.54M	3.25	$92.54M	$1.64	7.93
Crescent Capital BDC	$167.29M	2.89	$34.51M	$0.94	13.90

Summary

Crescent Capital BDC beats SLR Investment on 11 of the 20 factors compared between the two stocks.

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Bain Capital Specialty Finance (NYSE:BCSF) and Crescent Capital BDC (NASDAQ:CCAP) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.

Bain Capital Specialty Finance has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market.

Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 12.5%. Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 12.9%. Bain Capital Specialty Finance pays out 109.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out 178.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bain Capital Specialty Finance has increased its dividend for 4 consecutive years and Crescent Capital BDC has increased its dividend for 1 consecutive years.

Bain Capital Specialty Finance has a net margin of 27.00% compared to Crescent Capital BDC's net margin of 20.64%. Bain Capital Specialty Finance's return on equity of 10.44% beat Crescent Capital BDC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bain Capital Specialty Finance	27.00%	10.44%	4.35%
Crescent Capital BDC	20.64%	9.32%	4.07%

49.5% of Crescent Capital BDC shares are owned by institutional investors. 0.6% of Bain Capital Specialty Finance shares are owned by company insiders. Comparatively, 1.2% of Crescent Capital BDC shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Bain Capital Specialty Finance had 1 more articles in the media than Crescent Capital BDC. MarketBeat recorded 7 mentions for Bain Capital Specialty Finance and 6 mentions for Crescent Capital BDC. Crescent Capital BDC's average media sentiment score of 0.84 beat Bain Capital Specialty Finance's score of -0.62 indicating that Crescent Capital BDC is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bain Capital Specialty Finance	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Negative
Crescent Capital BDC	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Bain Capital Specialty Finance has higher revenue and earnings than Crescent Capital BDC. Bain Capital Specialty Finance is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bain Capital Specialty Finance	$273.24M	3.19	$98.76M	$1.53	8.78
Crescent Capital BDC	$167.29M	2.89	$34.51M	$0.94	13.90

Bain Capital Specialty Finance presently has a consensus price target of $14.00, suggesting a potential upside of 4.21%. Crescent Capital BDC has a consensus price target of $15.50, suggesting a potential upside of 18.59%. Given Crescent Capital BDC's stronger consensus rating and higher possible upside, analysts plainly believe Crescent Capital BDC is more favorable than Bain Capital Specialty Finance.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bain Capital Specialty Finance	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Crescent Capital BDC	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71

Summary

Bain Capital Specialty Finance beats Crescent Capital BDC on 10 of the 19 factors compared between the two stocks.

Get Crescent Capital BDC News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CCAP vs. The Competition

Export

Metric	Crescent Capital BDC	FIN Industry	Finance Sector	NASDAQ Exchange
Market Cap	$488.73M	$1.32B	$13.49B	$12.20B
Dividend Yield	12.71%	12.70%	5.81%	5.30%
P/E Ratio	13.90	10.73	23.13	25.58
Price / Sales	2.89	15.47	173.20	78.80
Price / Cash	7.70	7.37	20.50	55.34
Price / Book	0.68	0.83	2.14	6.66
Net Income	$34.51M	$118.06M	$1.11B	$333.63M
7 Day Performance	-3.90%	-4.34%	-1.14%	-0.12%
1 Month Performance	0.15%	-2.61%	0.14%	3.93%
1 Year Performance	-21.55%	-19.39%	10.81%	36.07%

Crescent Capital BDC Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCAP Crescent Capital BDC	3.9593 of 5 stars	$13.07 -1.1%	$15.50 +18.6%	-22.1%	$488.73M	$167.29M	13.90	N/A	News Coverage Earnings Report Dividend Cut
CGBD Carlyle Secured Lending	3.8953 of 5 stars	$12.09 +0.4%	$13.20 +9.2%	-21.6%	$847.82M	$80.99M	11.85	N/A	Positive News Earnings Report Analyst Forecast
MFIC MidCap Financial Investment	2.2856 of 5 stars	$12.23 +0.9%	$11.54 -5.7%	-13.8%	$1.13B	$320.88M	18.53	N/A
OCSL Oaktree Specialty Lending	3.1578 of 5 stars	$12.16 -5.7%	$12.17 +0.1%	-15.7%	$1.07B	$30.48M	33.78	N/A	High Trading Volume
SLRC SLR Investment	4.0869 of 5 stars	$15.97 +0.2%	$15.29 -4.3%	-20.5%	$871.32M	$218.54M	9.39	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CCAP) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Crescent Capital BDC (CCAP) Competitors

CCAP vs. CGBD, MFIC, OCSL, SLRC, and BCSF

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Summary

How does Crescent Capital BDC compare to MidCap Financial Investment?

Summary

How does Crescent Capital BDC compare to Oaktree Specialty Lending?

Summary

How does Crescent Capital BDC compare to SLR Investment?

Summary

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCAP vs. The Competition

Crescent Capital BDC Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Crescent Capital BDC (CCAP) Competitors

CCAP vs. CGBD, MFIC, OCSL, SLRC, and BCSF

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Which has better earnings and valuation, CCAP or CGBD?

Which has more volatility & risk, CCAP or CGBD?

Do analysts recommend CCAP or CGBD?

Is CCAP or CGBD more profitable?

Does the media prefer CCAP or CGBD?

Do institutionals and insiders hold more shares of CCAP or CGBD?

Is CCAP or CGBD a better dividend stock?

Summary

How does Crescent Capital BDC compare to MidCap Financial Investment?

Do institutionals & insiders believe in CCAP or MFIC?

Do analysts recommend CCAP or MFIC?

Is CCAP or MFIC a better dividend stock?

Is CCAP or MFIC more profitable?

Which has more risk and volatility, CCAP or MFIC?

Does the media favor CCAP or MFIC?

Which has preferable earnings & valuation, CCAP or MFIC?

Summary

How does Crescent Capital BDC compare to Oaktree Specialty Lending?

Is OCSL or CCAP a better dividend stock?

Which has more risk and volatility, OCSL or CCAP?

Do institutionals & insiders hold more shares of OCSL or CCAP?

Is OCSL or CCAP more profitable?

Do analysts rate OCSL or CCAP?

Does the media refer more to OCSL or CCAP?

Which has better valuation and earnings, OCSL or CCAP?

Summary

How does Crescent Capital BDC compare to SLR Investment?

Is SLRC or CCAP a better dividend stock?

Which has more risk and volatility, SLRC or CCAP?

Do institutionals & insiders hold more shares of SLRC or CCAP?

Is SLRC or CCAP more profitable?

Do analysts rate SLRC or CCAP?

Does the media refer more to SLRC or CCAP?

Which has better valuation and earnings, SLRC or CCAP?

Summary

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Which has more volatility and risk, BCSF or CCAP?

Is BCSF or CCAP a better dividend stock?

Is BCSF or CCAP more profitable?

Do institutionals and insiders believe in BCSF or CCAP?

Does the media prefer BCSF or CCAP?

Which has preferable earnings & valuation, BCSF or CCAP?

Do analysts recommend BCSF or CCAP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCAP vs. The Competition

Crescent Capital BDC Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools